Hosted on MSN31m
Novel Berberine Drug Cut HbA1c in Type 2 DiabetesMore participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback